Biyovent, a domestically produced intensive care mechanical ventilator (ICU) device that exemplifies Türkiye's "technological independence" reflex during the pandemic, is solidifying its place in hospitals. Produced in record time by the "National Consortium" formed by Biosys, Aselsan, Baykar, and Arçelik, Biyovent has reached 73 hospitals in 42 cities, becoming a "domestic powerhouse" in intensive care units.
During a time of crisis when countries around the world were engaged in mask wars and ventilators were being seized, Turkey managed to be one of the rare countries that could be self-sufficient. Turkish engineers achieved what was deemed "impossible," taking the prototype to mass production in just 14 days. Biovent, It is not just a medical device; it has gone down in history as Türkiye's defense industry initiative in the field of health.
Biovent Deployment in Numbers: 814 Devices in the Field
According to data shared by Biosys, the integration of the domestically produced ventilator into hospitals continues unabated. As part of the initial planning, this is happening across Türkiye. In 42 different cities And 73 critical hospitals Installations are complete. In total. 814 pieces Intensive care type mechanical ventilators have been made available for use by healthcare professionals.
These deliveries demonstrate that Türkiye is making access to high technology a standard not only in metropolises like Istanbul or Ankara, but also in hospitals across Anatolia.
Massive Collaboration: 4 Brands, One Goal
Behind Biyovent's success lies an unparalleled collaboration in engineering. This project brought together diverse talents from Turkish industry:
- Biosys: Research and development experience in the biomedical field and the basic design of the device.
- Baykar Defense: Speeding up the process with software, electronic hardware, and engineering support.
- Aselsan: Strong supply chain, display and electronic board design.
- Arçelik: Establishing mass production infrastructure with extensive production line experience.
This quartet demonstrated how a start-up idea (Biosys), combined with defense industry expertise (Baykar and Aselsan) and industrial manufacturing power (Arçelik), can be transformed into a global product.
Technical Superiority: Why Biovent?
Biyovent stands out from its competitors not only because it is "domestically produced," but also because of its technical specifications. Competing with devices sold by foreign rivals in the 20-30 thousand Euro range, Biyovent offers a much more cost-effective solution and distinguishes itself with the following features:
- User-Friendly Interface: Ergonomic screen designed with feedback from Turkish doctors.
- Advanced Breathing Modes: Ventilation options suitable for all patient types (Adult/Pediatric).
- High Security: Continuous operation and alarm systems.
The door to exports has been opened.
This successful distribution network within Turkey serves as a benchmark for Biyovent's global journey. Exported or donated as "Türkiye's breath" to numerous countries from Somalia to Brazil, these devices carry the vision of Turkish engineering's "Technology for the Benefit of Humanity" to the world.
Note
If you have any photos or video footage to support our news story, please share them with us using the information provided on our contact us page.
